Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs

European Journal of Medicinal Chemistry
P Crivori, I Poggesi

Abstract

The site of biotransformation, the extent and rate of metabolism and the number of active metabolic pathways are among the most important characteristics of the pharmacokinetics of a drug. The catalytic activity of drug metabolizing enzymes is likely the most influential determinant of the pharmacokinetic variability. Metabolic stability is the prerequisite for sustaining the therapeutically relevant concentrations. Metabolic inhibition and induction can give rise to clinically important drug-drug interactions. A variety of computational approaches are currently available for predicting different cytochrome P450 (CYP)-related metabolism endpoints. The present review will describe these approaches and their impact on drug development process. Indications on the available software for the implementation will also be given.

References

Apr 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D F LewisM H Tarbit
Aug 26, 1998·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D F Lewis
Mar 4, 2000·Science·I SchlichtingS G Sligar
Dec 18, 2001·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sean Ekins, Jon A Erickson
May 9, 2002·Drug Metabolism Reviews·David F V Lewis
May 17, 2002·Journal of Medicinal Chemistry·Angelo Vedani, Max Dobler
Aug 9, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Li XiaoK-C Cheng
Mar 4, 2003·Nature Reviews. Drug Discovery·Han van de Waterbeemd, Eric Gifford
Jul 10, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Arja AsikainenRisto O Juvonen
Jul 16, 2003·Nature·Pamela A WilliamsHarren Jhoti
Aug 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sean EkinsRichard K Harrison
Oct 8, 2003·Current Drug Metabolism·Dayna C Mankowski, Sean Ekins
Oct 8, 2003·Mini Reviews in Medicinal Chemistry·Franco LombardoMarina Y Shalaeva
Dec 4, 2003·Bioorganic & Medicinal Chemistry·Shahriar Haji-MomenianMilton L Brown
Jul 3, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Konstantin V BalakinTatiana Nikolskaya
Jul 23, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Konstantin V BalakinTatiana Nikolskaya
Jul 28, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D F V LewisP S Goldfarb

❮ Previous
Next ❯

Citations

May 3, 2011·Journal of Chemical Information and Modeling·Jed ZaretzkiCurt M Breneman
Feb 3, 2012·Journal of Natural Products·Nicholas M NjugunaKelly Chibale
May 3, 2011·Archives of Toxicology·Sarah AdlerJosé-Manuel Zaldivar
Jul 20, 2010·BMC Pharmacology·Nitish K MishraGajendra Ps Raghava
Feb 25, 2009·Expert Opinion on Drug Metabolism & Toxicology·Paul CzodrowskiThomas Fox
Aug 26, 2011·Expert Opinion on Drug Metabolism & Toxicology·Nitish Kumar Mishra
Aug 28, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kunal Roy, Partha Pratim Roy
Sep 30, 2015·Pharmaceutical Research·Alexander L PerrymanJoel S Freundlich
Jan 15, 2014·Journal of Biomolecular Structure & Dynamics·Lakshmi MagantiNanda Ghoshal
Oct 14, 2016·International Journal of Molecular Sciences·Shuai-Bing HeYan-Jiang Qiao
May 1, 2009·Bioanalysis·Olavi PelkonenHannu Raunio
Apr 29, 2015·Molecular BioSystems·Goutam MukherjeeB Jayaram
Oct 7, 2010·Journal of Computational Chemistry·Arthur N MayenoBrad Reisfeld
Jan 1, 2012·Molecular Informatics·Tao ZhangDongqing Wei
May 16, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·V V ShumyantsevaA I Archakov
Oct 24, 2009·ChemMedChem·Patrik RydbergLars Olsen
Dec 19, 2009·Alternatives to Laboratory Animals : ATLA·Angelo Vedani, Martin Smiesko
Feb 19, 2011·Biomedit︠s︡inskai︠a︡ khimii︠a︡·V V ShumiantsevaA I Archakov
Apr 24, 2012·Toxicology and Applied Pharmacology·Angelo VedaniMartin Smieško
Apr 17, 2008·Journal of Chemical Information and Modeling·Jihoon JungKyoung Tai No
Jul 5, 2007·Journal of Chemical Information and Modeling·Lothar TerflothJohann Gasteiger
May 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Daria KupczykAlina Woźniak
Jun 10, 2010·ACS Medicinal Chemistry Letters·Patrik RydbergLars Olsen
Jun 10, 2010·Journal of Chemical Information and Modeling·Lisa Michielan, Stefano Moro
Jul 12, 2019·Chemical Reviews·Xin YangShengyong Yang
Aug 8, 2017·Journal of Chemical Information and Modeling·Martin ŠíchoJohannes Kirchmair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.